PRIVIA HEALTH GROUP INC (PRVA) Forecast, Price Target & Analyst Ratings

NASDAQ:PRVA • US74276R1023

Current stock price

20.14 USD
-0.4 (-1.95%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PRIVIA HEALTH GROUP INC (PRVA).

Forecast Snapshot

Consensus Price Target

Price Target
$32.15
+ 59.65% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
$0.08
Revenue Estimate
573.35M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.29%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$32.15
Upside
+ 59.65%
From current price of $20.14 to mean target of $32.15, Based on 28 analyst forecasts
Low
$23.23
Median
$31.62
High
$38.85

Price Target Revisions

1 Month
0.00%
3 Months
-0.08%

Price Target Summary

28 Wall Street analysts provided a forecast for the next 12 months for PRVA. The average price target is 32.15 USD. This implies a price increase of 59.65% is expected in the next year compared to the current price of 20.14.
The average price target has been revised downward by 0.08% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

PRVA Current Analyst RatingPRVA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15

Analyst Ratings History

PRVA Historical Analyst RatingsPRVA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
84.29%
PRVA was analyzed by 28 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about PRVA.
In the previous month the buy percentage consensus was at a similar level.
PRVA was analyzed by 28 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-25BarclaysMaintains Equal-Weight -> Equal-Weight
2026-03-03CitigroupMaintains Buy -> Buy
2026-03-02Truist SecuritiesMaintains Buy -> Buy
2026-02-27Canaccord GenuityMaintains Buy -> Buy
2026-01-09RBC CapitalReiterate Outperform
2025-12-04Stephens & Co.Reiterate Overweight -> Overweight
2025-11-13BMO CapitalInitiate Outperform
2025-11-13JP MorganMaintains Overweight -> Overweight
2025-11-12Canaccord GenuityMaintains Buy -> Buy
2025-11-10BarclaysMaintains Equal-Weight -> Equal-Weight
2025-11-10Truist SecuritiesReiterate Buy -> Buy
2025-11-07CitizensMaintains Market Outperform -> Market Outperform
2025-11-07Evercore ISI GroupMaintains Outperform -> Outperform
2025-10-09BarclaysMaintains Equal-Weight -> Equal-Weight
2025-09-24Stephens & Co.Reiterate Overweight -> Overweight
2025-09-04Stephens & Co.Reiterate Overweight -> Overweight
2025-08-29JMP SecuritiesMaintains Market Outperform -> Market Outperform
2025-08-11Piper SandlerMaintains Overweight -> Overweight
2025-07-09Evercore ISI GroupMaintains Outperform -> Outperform
2025-05-28JP MorganMaintains Overweight -> Overweight
2025-05-27BarclaysMaintains Equal-Weight -> Equal-Weight
2025-04-28JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-04-15BairdMaintains Outperform -> Outperform
2025-04-10NeedhamReiterate Buy -> Buy
2025-04-10BarclaysMaintains Equal-Weight -> Equal-Weight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
$0.08
Revenue Estimate
573.35M
Revenue Q2Q
-28.21%
EPS Q2Q
162.11%
Number of Analysts
22

Next Earnings Revisions

Revenue (1 Month)
-4.38%
Revenue (3 Months)
-31.33%
EPS (1 Month)
13.87%
EPS (3 Months)
13.87%

Next Earnings Summary

PRVA is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is 0.08 USD and the consensus revenue estimate is 573.35M USD.
The next earnings revenue estimate has been revised downward by 31.33% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2031

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
PRVA revenue by date.PRVA revenue by date.
1.658B
22.19%		1.736B
4.74%		2.123B
22.26%		2.434B
14.66%		2.689B
10.48%		2.998B
11.49%		3.193B
6.50%		3.515B
10.08%		3.374B
-4.01%
EBITDA
YoY % growth
PRVA ebitda by date.PRVA ebitda by date.
27.182M
287.08%		24.25M
-10.79%		44.142M
82.03%		150.17M
240.20%		173.81M
15.74%		210.99M
21.39%		222.21M
5.32%		249.44M
12.25%		297.13M
19.12%
EBIT
YoY % growth
PRVA ebit by date.PRVA ebit by date.
20.649M
208.11%		16.982M
-17.76%		34.235M
101.60%		75.936M
121.81%		106.85M
40.71%		126.76M
18.63%		125.77M
-0.78%		148.16M
17.80%		215.93M
45.74%
Operating Margin
PRVA operating margin by date.PRVA operating margin by date.
1.25%0.98%1.61%3.12%3.97%4.23%3.94%4.22%6.40%
EPS
YoY % growth
PRVA eps by date.PRVA eps by date.
0.19
46.15%		0.11
-42.11%		0.17
54.55%		0.35
106.06%		0.47
32.97%		0.66
41.79%		N/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.08
162.11%		0.08
285.46%		0.10
96.02%		0.08
18.29%		0.09
12.43%		0.10
27.90%		0.11
11.01%		0.14
64.24%
Revenue
Q2Q % growth		573.35M
-28.21%		616.77M
-28.52%		921.89M
-1.97%		900.86M
66.46%		1.019B
77.73%		1.049B
70.08%		1.083B
17.48%		1.11B
23.22%
EBITDA
Q2Q % growth		34.944M
390.86%		36.335M
364.64%		40.23M
85.79%		36.892M
74.14%		37.586M
7.56%		39.437M
8.54%		42.568M
5.81%		47.437M
28.58%
EBIT
Q2Q % growth		20.027M
283.81%		23.87M
615.53%		12.909M
-10.37%		15.042M
33.37%		12.828M
-35.95%		14.552M
-39.04%		16.725M
29.56%		21.77M
44.73%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PRVA Yearly Revenue VS EstimatesPRVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
PRVA Yearly EPS VS EstimatesPRVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 -1 -1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
57.20%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
11.91%
Revenue Next 5 Year
10.44%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
100.08%
EBIT Next 5 Year
56.77%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

PRIVIA HEALTH GROUP INC / PRVA Forecast FAQ

Can you provide the average price target for PRIVIA HEALTH GROUP INC stock?

28 analysts have analysed PRVA and the average price target is 32.15 USD. This implies a price increase of 59.65% is expected in the next year compared to the current price of 20.14.

Can you provide the upcoming earnings date for PRIVIA HEALTH GROUP INC?

PRIVIA HEALTH GROUP INC (PRVA) will report earnings on 2026-05-06, before the market open.

Can you provide the consensus estimates for PRIVIA HEALTH GROUP INC next earnings?

The consensus EPS estimate for the next earnings of PRIVIA HEALTH GROUP INC (PRVA) is 0.08 USD and the consensus revenue estimate is 573.35M USD.

What is the expected long term growth rate for PRIVIA HEALTH GROUP INC (PRVA)?

The expected long term growth rate for PRIVIA HEALTH GROUP INC (PRVA) is 11.91%.